BMS has welcomed the recently announced listing of immunotherapy combination OPDIVO (nivolumab) in combination with YERVOY (ipilimumab) for the treatment of advanced renal cell carcinoma. …
Latest Video
New Stories
-
Professor Brendan Murphy: Repurposing will take 'just a few weeks'
August 14, 2020 - - Latest News -
QBiotics in new cancer collaboration with MSD
August 14, 2020 - - Latest News -
Is the pandemic a time for caution or action on innovation?
August 14, 2020 - - Latest News -
Merck marks a critical National Science Week
August 14, 2020 - - Latest News -
Support for an extension but not at any price
August 14, 2020 - - Latest News -
The COVID-19 vaccine manufacturing and supply deals
August 13, 2020 - - Latest News -
Dr Brendan Shaw: A presidential order with 'serious implications' for Australia
August 13, 2020 - - Latest News